These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

241 related articles for article (PubMed ID: 29982453)

  • 1. Human airway mucus alters susceptibility of Pseudomonas aeruginosa biofilms to tobramycin, but not colistin.
    Müller L; Murgia X; Siebenbürger L; Börger C; Schwarzkopf K; Sewald K; Häussler S; Braun A; Lehr CM; Hittinger M; Wronski S
    J Antimicrob Chemother; 2018 Oct; 73(10):2762-2769. PubMed ID: 29982453
    [TBL] [Abstract][Full Text] [Related]  

  • 2. PEGylation of Tobramycin Improves Mucus Penetration and Antimicrobial Activity against Pseudomonas aeruginosa Biofilms in Vitro.
    Bahamondez-Canas TF; Zhang H; Tewes F; Leal J; Smyth HDC
    Mol Pharm; 2018 Apr; 15(4):1643-1652. PubMed ID: 29514003
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The MerR-like regulator BrlR impairs Pseudomonas aeruginosa biofilm tolerance to colistin by repressing PhoPQ.
    Chambers JR; Sauer K
    J Bacteriol; 2013 Oct; 195(20):4678-88. PubMed ID: 23935054
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of oxygen limitation on the in vitro antimicrobial susceptibility of clinical isolates of Pseudomonas aeruginosa grown planktonically and as biofilms.
    Field TR; White A; Elborn JS; Tunney MM
    Eur J Clin Microbiol Infect Dis; 2005 Oct; 24(10):677-87. PubMed ID: 16249934
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antimicrobial efficacy against Pseudomonas aeruginosa biofilm formation in a three-dimensional lung epithelial model and the influence of fetal bovine serum.
    Crabbé A; Liu Y; Matthijs N; Rigole P; De La Fuente-Nùñez C; Davis R; Ledesma MA; Sarker S; Van Houdt R; Hancock RE; Coenye T; Nickerson CA
    Sci Rep; 2017 Mar; 7():43321. PubMed ID: 28256611
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Activity of Antibiotics against Pseudomonas aeruginosa in an
    Diaz Iglesias Y; Van Bambeke F
    Antimicrob Agents Chemother; 2020 Mar; 64(4):. PubMed ID: 32015047
    [No Abstract]   [Full Text] [Related]  

  • 7. Increased bactericidal activity of colistin on Pseudomonas aeruginosa biofilms in anaerobic conditions.
    Kolpen M; Appeldorff CF; Brandt S; Mousavi N; Kragh KN; Aydogan S; Uppal HA; Bjarnsholt T; Ciofu O; Høiby N; Jensen PØ
    Pathog Dis; 2016 Feb; 74(1):ftv086. PubMed ID: 26458402
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impairment of Pseudomonas aeruginosa Biofilm Resistance to Antibiotics by Combining the Drugs with a New Quorum-Sensing Inhibitor.
    Furiga A; Lajoie B; El Hage S; Baziard G; Roques C
    Antimicrob Agents Chemother; 2015 Dec; 60(3):1676-86. PubMed ID: 26711774
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Breaking the Vicious Cycle of Antibiotic Killing and Regrowth of Biofilm-Residing
    Müsken M; Pawar V; Schwebs T; Bähre H; Felgner S; Weiss S; Häussler S
    Antimicrob Agents Chemother; 2018 Dec; 62(12):. PubMed ID: 30297365
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A pulmonary mucus surrogate for investigating antibiotic permeation and activity against Pseudomonas aeruginosa biofilms.
    Frisch S; Boese A; Huck B; Horstmann JC; Ho DK; Schwarzkopf K; Murgia X; Loretz B; de Souza Carvalho-Wodarz C; Lehr CM
    J Antimicrob Chemother; 2021 May; 76(6):1472-1479. PubMed ID: 33712824
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Does the mode of dispersion determine the properties of dispersed Pseudomonas aeruginosa biofilm cells?
    Wille J; Teirlinck E; Sass A; Van Nieuwerburgh F; Kaever V; Braeckmans K; Coenye T
    Int J Antimicrob Agents; 2020 Dec; 56(6):106194. PubMed ID: 33039591
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Polyester-based particles to overcome the obstacles of mucus and biofilms in the lung for tobramycin application under static and dynamic fluidic conditions.
    Ernst J; Klinger-Strobel M; Arnold K; Thamm J; Hartung A; Pletz MW; Makarewicz O; Fischer D
    Eur J Pharm Biopharm; 2018 Oct; 131():120-129. PubMed ID: 30063969
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vitro evaluation of tobramycin and aztreonam versus Pseudomonas aeruginosa biofilms on cystic fibrosis-derived human airway epithelial cells.
    Yu Q; Griffin EF; Moreau-Marquis S; Schwartzman JD; Stanton BA; O'Toole GA
    J Antimicrob Chemother; 2012 Nov; 67(11):2673-81. PubMed ID: 22843834
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Susceptibility of Pseudomonas aeruginosa Dispersed Cells to Antimicrobial Agents Is Dependent on the Dispersion Cue and Class of the Antimicrobial Agent Used.
    Chambers JR; Cherny KE; Sauer K
    Antimicrob Agents Chemother; 2017 Dec; 61(12):. PubMed ID: 28971863
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Colistin-tobramycin combinations are superior to monotherapy concerning the killing of biofilm Pseudomonas aeruginosa.
    Herrmann G; Yang L; Wu H; Song Z; Wang H; Høiby N; Ulrich M; Molin S; Riethmüller J; Döring G
    J Infect Dis; 2010 Nov; 202(10):1585-92. PubMed ID: 20942647
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Use of Calgary and Microfluidic BioFlux Systems To Test the Activity of Fosfomycin and Tobramycin Alone and in Combination against Cystic Fibrosis Pseudomonas aeruginosa Biofilms.
    Díez-Aguilar M; Morosini MI; Köksal E; Oliver A; Ekkelenkamp M; Cantón R
    Antimicrob Agents Chemother; 2018 Jan; 62(1):. PubMed ID: 29084746
    [No Abstract]   [Full Text] [Related]  

  • 17. Role of Viscoelasticity in Bacterial Killing by Antimicrobials in Differently Grown
    Rozenbaum RT; van der Mei HC; Woudstra W; de Jong ED; Busscher HJ; Sharma PK
    Antimicrob Agents Chemother; 2019 Apr; 63(4):. PubMed ID: 30745390
    [No Abstract]   [Full Text] [Related]  

  • 18. Asiatic acid and corosolic acid enhance the susceptibility of Pseudomonas aeruginosa biofilms to tobramycin.
    Garo E; Eldridge GR; Goering MG; DeLancey Pulcini E; Hamilton MA; Costerton JW; James GA
    Antimicrob Agents Chemother; 2007 May; 51(5):1813-7. PubMed ID: 17353241
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tobramycin-Treated Pseudomonas aeruginosa PA14 Enhances Streptococcus constellatus 7155 Biofilm Formation in a Cystic Fibrosis Model System.
    Price KE; Naimie AA; Griffin EF; Bay C; O'Toole GA
    J Bacteriol; 2016 Jan; 198(2):237-47. PubMed ID: 26483523
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Use of artificial sputum medium to test antibiotic efficacy against Pseudomonas aeruginosa in conditions more relevant to the cystic fibrosis lung.
    Kirchner S; Fothergill JL; Wright EA; James CE; Mowat E; Winstanley C
    J Vis Exp; 2012 Jun; (64):e3857. PubMed ID: 22711026
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.